TRICARE step therapy denied: how to appeal

Quick answer

If TRICARE denied your step therapy override, you can appeal, and the plan must give you its file and the criteria it used. You have 90 days from the notice (TRICARE) to file. The date printed on your denial notice controls; it can only be later than these floors, never earlier.

Why TRICARE denies step therapy override

TRICARE is the U.S. Department of Defense health program covering active-duty servicemembers, retirees, and eligible family members. Appeals are governed by 32 CFR Part 199, administered by regional contractors (Humana Military and TriWest), with final review by the Defense Health Agency (DHA).

For step therapy override specifically: Step therapy (also called 'fail-first') requires patients to try a plan-preferred medication and demonstrate failure or intolerance before the plan will cover the prescribed drug. Federal and many state laws require plans to allow exception requests when the step is clinically inappropriate.

The law that controls this appeal

Federal and state step-therapy override laws require an exception for contraindication, intolerance, prior failure, or likely ineffectiveness.

Note for TRICARE: where the standard above cites ERISA or the ACA appeal rules, those describe employer and Marketplace plans. The windows and levels that apply to TRICARE are in the table below.

At a glance

TRICARE appeals: the rule, the deadline and the next level, by plan type

TRICARE is a federal programme with its own appeal rules. State external review, ERISA and the ACA appeal rules do not apply.

Plan type	Rule that governs	File your appeal within	The plan must answer	If the plan says no again
TRICARE Active-duty families, retirees and their families. Claims are handled by Humana Military (East) or TriWest (West) under the Defense Health Agency.	32 CFR 199.10 (appeal and hearing procedures) and the TRICARE Operations Manual, Chapter 12. ERISA, the ACA appeal rules and state external review do not apply.	Reconsideration: 90 days from the date of the notice of the initial determination. Formal review by the Defense Health Agency: 60 days from the reconsideration decision. Hearing: 60 days from the formal-review decision (32 CFR 199.10).	Expedited review is available for pre-admission and pre-authorization denials; the contractor's clock for a standard reconsideration is stated in the letter.	Formal review by the DHA, an independent hearing when the amount in controversy meets the threshold in 32 CFR 199.10(d), and a final decision by the DHA Director.

TRICARE

What you can demand. The sponsor, the beneficiary, a participating provider or an appointed representative can appeal. Ask the contractor for the file and the medical-necessity criteria it applied.

How to open the appeal. Cite 32 CFR 199.10 and the benefit rule in 32 CFR 199.4: state the appeal type, address it to the regional contractor named on the letter, and request the criteria used.

Primary sources for this table

Windows are federal floors or the rule as written; the denial notice controls. Reviewed 13 September 2026. General information, not legal advice; Apellica is not a law firm.

What TRICARE denies for step therapy override

The step therapy override services most often denied:

Biologics for rheumatoid arthritis, psoriasis, Crohn's, ulcerative colitis
MS disease-modifying therapies
GLP-1s when a less-effective oral is preferred
Newer migraine therapies (CGRP inhibitors)
Specialty oncology when older regimens are preferred

Why step therapy override claims get denied

A typical TRICARE step therapy override denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:

Patient has not tried and failed the preferred drug
Documentation of prior trial / failure is incomplete
Plan does not recognize prior trial done under previous plan
Contraindication or intolerance not documented in record

The TRICARE appeal process

Appeal levels: Contractor reconsideration, formal review by DHA, then independent hearing (above the amount-in-controversy threshold), then DHA Director final decision.

Carrier timing: 90 days from denial for reconsideration; 60 days from each subsequent adverse decision for the next level. Urgent / pre-authorization timelines compress to 72 hours.

Step therapy timing for TRICARE: the filing windows and decision clocks in the table above apply; the date on the notice controls.

What we know about TRICARE: TRICARE rules are federal, state DOI external review does not apply. We brief appeals against 32 CFR Part 199 and the TRICARE Operations Manual specifically.

Common TRICARE denial patterns for step therapy override

Regional contractor reconsideration first. TRICARE appeals begin with reconsideration by the regional managed care support contractor, Humana Military (East) or TriWest (West). The reconsideration request must be in writing and is typically due within 90 days of the initial denial.
Formal review by DHA. After contractor reconsideration, members can request a formal review by the Defense Health Agency. This step is the gateway to a hearing and is the prerequisite to any further federal review.
Independent hearing for higher-dollar cases. TRICARE provides an independent hearing for appeals meeting a minimum amount-in-controversy threshold. The hearing officer's recommendation goes to the DHA Director for a final agency decision.

How to win your TRICARE step therapy override appeal

Strategy for step therapy override: File a step-therapy override request citing one of the standard override grounds: (1) prior trial and failure of the preferred drug, (2) contraindication to the preferred drug, (3) intolerance / adverse reaction, (4) likely-ineffective based on clinical characteristics, or (5) stability on current therapy. Attach prior pharmacy records from any plan to demonstrate prior trials. Many state laws now codify a tight response timeline for step-therapy overrides, cite the applicable statute.

Filed against TRICARE, that strategy rides on this procedural spine:

Procedural-rights anchor. Cite 32 CFR 199.10 and the benefit rule in 32 CFR 199.4: state the appeal type, address it to the regional contractor named on the letter, and request the criteria used.
Criteria-disclosure demand. TRICARE frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
Controlling-standard citation. Federal and state step-therapy override laws require an exception for contraindication, intolerance, prior failure, or likely ineffectiveness.
Treating-provider attestation. A letter from the treating physician addressing each criterion in TRICARE's own policy language. This is the single strongest evidentiary element.
Requested action. A specific demand to reverse the step therapy override denial and approve the service, not a general "please reconsider."

Documents you'll need for your TRICARE step therapy override appeal

Denial letter
Prescription record from current and prior plans
Prescriber's letter documenting clinical rationale and any prior trials
Documentation of contraindication or intolerance (if applicable)
Relevant lab values or imaging supporting indication

What a step therapy override appeal can recover

Typical recovery for step therapy override cases runs $500 - $30,000+ per month of medication. The exact figure depends on the specific service and your plan's contracted rates.

TRICARE step therapy override appeals: frequently asked questions

Can I get your TRICARE step therapy requirement waived?

Yes, through a step-therapy override request. Federal and many state laws require plans to grant an exception when the required first-line drug is clinically inappropriate for you.

What are the grounds for a step-therapy override?

Prior trial and failure of the preferred drug, a contraindication to it, an intolerance or adverse reaction, a clinical likelihood that it will be ineffective, or current stability on the prescribed therapy. Any one is sufficient.

How fast must TRICARE respond to an override request?

A standard exception is typically decided within 72 hours and an urgent one within 24 hours. Many state step-therapy laws codify a 72-hour-or-less response requirement.

What if my prior drug trial was under a different plan?

Bring it anyway. Pharmacy records from any prior plan can document a prior trial and failure; plans sometimes refuse to recognize outside trials, but the records are strong evidence on appeal.

What Apellica does for TRICARE step therapy override appeals

We file appeals against TRICARE specifically configured to its internal review process. Every step therapy override appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.

Cost: $0 upfront. We work on contingency for TRICARE appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.

Start your TRICARE step therapy override appeal

Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.

Start free appeal review →

TRICARE denied your step therapy override? Here is what to do next